These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29600179)

  • 21. Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study.
    Bogan CM; Kaczmarek JV; Pierce JM; Chen SC; Boyd KL; Calcutt MW; Bridges TM; Lindsley CW; Nadelmann JB; Liao A; Hsieh T; Abramson DH; Francis JH; Friedman DL; Richmond A; Daniels AB
    Br J Ophthalmol; 2022 Feb; 106(2):288-296. PubMed ID: 33972235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined intravitreal melphalan and intravenous/intra-arterial chemotherapy for retinoblastoma with vitreous seeds.
    Lee JH; Han JW; Hahn SM; Lyu CJ; Kim DJ; Lee SC
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):391-4. PubMed ID: 26511530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma.
    Rao R; Honavar SG; Sharma V; Reddy VAP
    Br J Ophthalmol; 2018 Apr; 102(4):490-495. PubMed ID: 28844050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Survival Following Intravitreal Melphalan as Adjuvant Treatment for Vitreous Retinoblastoma Seeding.
    Alahmadi G; Maktabi AMY; Sesma G; Almesfer S
    Clin Ophthalmol; 2023; 17():1789-1800. PubMed ID: 37377999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal Topotecan for Vitreous Seeds in Retinoblastoma: A Long-term Review of 91 Eyes.
    Sen M; Rao R; Mulay K; Reddy VAP; Honavar SG
    Ophthalmology; 2024 Oct; 131(10):1215-1224. PubMed ID: 38703794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Rare Case of Acute Hemorrhagic Retinopathy Following Intravitreal Melphalan Injection for Persistent Vitreous Seeds in Retinoblastoma.
    Rajan RP; Kim U; Maitray A; Jena S; Sen S
    J Vitreoretin Dis; 2022; 6(2):155-157. PubMed ID: 37008661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients.
    Xue K; Ren H; Meng F; Zhang R; Qian J
    BMC Ophthalmol; 2019 Feb; 19(1):61. PubMed ID: 30808420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of retrobulbar and sub-Tenon's capsule injection of local anesthetic in vitreoretinal surgery.
    Lai MM; Lai JC; Lee WH; Huang JJ; Patel S; Ying HS; Melia M; Haller JA; Handa JT
    Ophthalmology; 2005 Apr; 112(4):574-9. PubMed ID: 15808246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitreous Seed Classification and Regression Patterns in Eyes With Retinoblastoma.
    Rishi P; Attiku Y; Manchegowda PT; Agarwal A; Sharma M
    J Vitreoretin Dis; 2021; 5(2):121-129. PubMed ID: 37009089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
    Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
    Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Posterior sub-tenon's bevacizumab injection in diabetic macular edema; a pilot study.
    Falavarjani KG; Khadamy J; Karimi Moghaddam A; Karimi N; Modarres M
    Saudi J Ophthalmol; 2015; 29(4):270-3. PubMed ID: 26586977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular safety of repeated intravitreal injections of Carboplatin and Digoxin: A preclinical study on the healthy rabbits.
    Khodabande A; Ghassemi F; Asadi Amoli F; Riazi-Esfahani H; Mahmoudzadeh R; Mehrpour M; Valipour N
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00814. PubMed ID: 34250764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study.
    Francis JH; Schaiquevich P; Buitrago E; Del Sole MJ; Zapata G; Croxatto JO; Marr BP; Brodie SE; Berra A; Chantada GL; Abramson DH
    Ophthalmology; 2014 Sep; 121(9):1810-7. PubMed ID: 24819859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective study of sub-Tenon's versus retrobulbar anesthesia for inpatient and day-surgery trabeculectomy.
    Buys YM; Trope GE
    Ophthalmology; 1993 Oct; 100(10):1585-9. PubMed ID: 8414420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal Lower-Dose (20 µg) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds.
    Tuncer S; Balcı Ö; Tanyıldız B; Kebudi R; Shields CL
    Ophthalmic Surg Lasers Imaging Retina; 2015 Oct; 46(9):942-8. PubMed ID: 26469234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined intravitreal and subconjunctival carboplatin for retinoblastoma with vitreous seeds.
    Smith SJ; Pulido JS; Salomão DR; Smith BD; Mohney B
    Br J Ophthalmol; 2012 Aug; 96(8):1073-7. PubMed ID: 22368261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trans-Tenon's retrobulbar triamcinolone acetonide infusion for refractory diabetic macular edema after vitrectomy.
    Koga T; Mawatari Y; Inumaru J; Fukushima M; Tanihara H
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1247-52. PubMed ID: 16021497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.